2012
DOI: 10.1186/1472-6882-12-138
|View full text |Cite
|
Sign up to set email alerts
|

Protective effect of guggulsterone against cardiomyocyte injury induced by doxorubicin in vitro

Abstract: BackgroundDoxorubicin (DOX) is an effective antineoplastic drug; however, clinical use of DOX is limited by its dose-dependent cardiotoxicity. It is well known that reactive oxygen species (ROS) play a vital role in the pathological process of DOX-induced cardiotoxicity. For this study, we evaluated the protective effects of guggulsterone (GS), a steroid obtained from myrrh, to determine its preliminary mechanisms in defending against DOX-induced cytotoxicity in H9C2 cells.MethodsIn this study, we used a 3-(4,… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
10
0
1

Year Published

2012
2012
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 18 publications
(11 citation statements)
references
References 42 publications
0
10
0
1
Order By: Relevance
“…There is evidence showing that the use of guggulsterone at the doses of 10-30 μM significantly reduced the formation of MDA and suppressed caspase-3 activity to reference levels in doxorubicin-induced cytotoxicity and cell death in H9C2 cell line. 36 The beneficial effects of EEM found in the present study might be attributed to its phytochemical compounds.…”
Section: Discussionmentioning
confidence: 52%
“…There is evidence showing that the use of guggulsterone at the doses of 10-30 μM significantly reduced the formation of MDA and suppressed caspase-3 activity to reference levels in doxorubicin-induced cytotoxicity and cell death in H9C2 cell line. 36 The beneficial effects of EEM found in the present study might be attributed to its phytochemical compounds.…”
Section: Discussionmentioning
confidence: 52%
“…Відомо, що важливу роль у розвитку кардіотоксичності, зумовленої доксорубіцином, відіграють активні форми кисню (АФК) [1]. Одним із механізмів пошкоджень міокарда доксорубіцином є роз-балансування активності антиоксидантних ензимів у тканині серця, зокрема каталази, глутатіонпероксидази та супероксиддисмутази [2].…”
unclassified
“…10 GS has aroused considerable interest as an active gugulipid component, exerting diverse pharmacologic reactions, including anti-inflammatory, hypolipidemic, antineoplastic, antioxidative, antidiabetic, and cardioprotective effects. 9,[21][22][23][24][25][26] In this study, we illustrate the significant ability of GS to suppress the elevated production of proinflammatory mediators in IL-1β-stimulated GO and non-GO fibroblasts. Additionally, GS attenuated adipogenesis and hyaluronan production.…”
Section: Discussionmentioning
confidence: 83%